The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of degarelix/bicalutamide combination for prostate cancer.
 
Masahiro Nozawa
Consulting or Advisory Role - Astellas Pharma; Novartis; Pfizer; Sanofi
Speakers' Bureau - GlaxoSmithKline; Novartis; Pfizer; Sanofi
Research Funding - Astellas Pharma (Inst); Pfizer (Inst); Sanofi (Inst)
 
Takahide Sugiyama
No Relationships to Disclose
 
Koichi Sugimoto
No Relationships to Disclose
 
Tasuharu Nagai
No Relationships to Disclose
 
Yuji Hatanaka
No Relationships to Disclose
 
Takashi Oki
No Relationships to Disclose
 
Hideo Tahara
No Relationships to Disclose
 
Hisao Matsuda
No Relationships to Disclose
 
Hirotsugu Uemura
Consulting or Advisory Role - Astellas Pharma; Novartis; Ono Pharmaceutical; Pfizer; Sanofi; Takeda
Speakers' Bureau - GlaxoSmithKline; Novartis; Pfizer; Sanofi
Research Funding - Astellas Pharma (Inst); Janssen (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sanofi (Inst); Takeda (Inst)